Crude Oil Rises 1%; Mustang Bio Shares Spike Higher

U.S. stocks traded mixed midway through trading, with the S&P 500 edging higher on Monday.

The Dow traded up 0.08% to 38,618.63 while the NASDAQ rose 0.20% to 17,724.07. The S&P 500 also rose, gaining, 0.24% to 5,444.69.

Check This Out: Top 4 Risk Off Stocks That May Rocket Higher In Q2

Leading and Lagging Sectors

Consumer staples shares jumped by 0.4% on Monday.

In trading on Monday, utilities shares fell by 1%.

Top Headline

The NY Empire State Manufacturing Index rose to -6 in June versus a reading of -15.6 in May and coming in better than market expectations of -12.50.

Equities Trading UP
                       

• Mustang Bio, Inc. MBIO shares shot up 240% to $0.4399 after the company announced safety and efficacy data from the complete Waldenstrom Macroglobulinemia cohort of its Phase 1/2 clinical trial of MB-106, showing an overall response rate of 90% with one patient remaining in complete remission at 31 months.
• Shares of Allego N.V. ALLG got a boost, surging 127% to $1.67 after the company and its majority shareholder, Meridiam, announced a transaction framework agreement under which Meridiam will launch a tender offer for all issued and outstanding Allego shares not owned by Meridiam, with the option to tender shares for $1.70 per share in cash.
• The Aaron’s Company, Inc. AAN shares were also up, gaining 32% to $9.98 after the company announced that it entered into a definitive agreement to be acquired by IQVentures Holdings.

Equities Trading DOWN

• Aerovate Therapeutics, Inc. AVTE shares dropped 91% to $2.21. Aerovate Therapeutics released topline results from the Phase 2b portion of the IMPAHCT Phase 2b/3 trial of AV-101, a dry powder inhaled formulation of imatinib, for pulmonary arterial hypertension (PAH).
• Shares of Workhorse Group Inc. WKHS were down 20% to $2.3950 as the stock begins trading on a split-adjusted basis. Workhorse announced a 1-for-20 reverse stock split of its common stock last week after shareholders approved the move at the company's annual meeting of stockholders in May.
• Ovid Therapeutics Inc OVID was down, falling 68% to $1.04 after Takeda’s Skyline study in Dravet syndrome missed its primary endpoint

Also Check This Out: How To Earn $500 A Month From Steelcase Stock Ahead Of Q1 Earnings Report

Commodities

In commodity news, oil traded up 1.2% to $79.36 while gold traded down 0.4% at $2,339.00.

Silver traded up 0.1% to $29.485 on Monday, while copper fell 1.7% to $4.4210.

Euro zone

European shares were mostly lower today. The eurozone's STOXX 600 slipped 0.02%, Germany's DAX rose 0.27% and France's CAC 40 gained 0.67%. Spain's IBEX 35 Index fell 0.50%, while London's FTSE 100 slipped 0.15%.

Wages in the Eurozone increased 5.3% year-over-year in the first quarter, while hourly labor costs climbed by 5.1% annually in the quarter.

Spain’s trade gap widened to EUR 4.7 billion in April from EUR 4.4 billion in the year-ago month. Italy's annual inflation rate came in unchanged at 0.8% in May.

Asia Pacific Markets

Asian markets closed lower on Monday, with Japan's Nikkei falling 1.83%, Hong Kong's Hang Seng Index declining 0.03% and China's Shanghai Composite Index dipping 0.55%.

China’s retail sales climbed by 3.7% year-over-year in May, while industrial production rose by 5.6% year-over-year in May. China's new home prices fell by 3.9% year-over-year during the month of May. The People's Bank of China kept the interest rate unchanged at 2.50% during its recent meeting. Japanese core machinery orders slipped l 2.9% month-over-month to 885.3 billion yen in April.

Economics

The NY Empire State Manufacturing Index rose to -6 in June versus a reading of -15.6 in May and coming in better than market expectations of -12.50.

Now Read This: This Analyst With 86% Accuracy Rate Sees Over 13% Upside In Alphabet – Here Are 5 Stock Picks For Last Week From Wall Street’s Most Accurate Analysts